产品图片
货号/SKU
NR-52168
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-52168??Acinetobacter baumannii, MRSN 6541(Bacteria)|Acinetobacter baumannii|MRSN 6541|-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 6541, NR-52168. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Acinetobacter baumannii (A. baumannii), strain MRSN 6541 was isolated in 2012 from a human wound in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 6541 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52168 was deposited as multi-locus sequence type (MLST) ST 1, sensitive to amikacin, ceftazidime, colistin, gentamicin, tobramycin and tetracycline and resistant to ciprofloxacin, cefepime, imipenem, levofloxacin, meropenem, trimethoprim/sulfamethoxazole, and ampicillin/sulbactam with intermediate resistance to ceftriaxone. Strain MRSN 6541 is reported to have two aminoglycoside transferase genes [aadA2 and ant(2”)-Ia; conferring resistance to various aminoglycosides], four beta-lactamase genes (blaADC-25, blacarb-2, blaOAX-25 and blaOXA-69; conferring resistance to beta-lactams), a chloramphenicol acetyltransferase gene (catB3; conferring resistance to chloramphenicol), a chloramphenicol exporter gene (cmlA1; conferring resistance to chloramphenicol), a dihydrofolate reductase (dfrA19; conferring resistance to trimethoprim), a macrolide phosphotransferase [mph(E), conferring resistance to macrolides], a ABC-F type ribosomal protection protein /ABC-F subfamily protein gene [msr(E); conferring resistance to erythromycin and streptogramin B] and a sulfonamide resistance gene (sul2; conferring resistance to sulfonamides) The complete genome of A. baumannii, strain MRSN 6541 is available (GenBank: VHEK00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Acinetobacter baumannii (A. baumannii), strain MRSN 6541 was isolated in 2012 from a human wound in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 6541 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52168 was deposited as multi-locus sequence type (MLST) ST 1, sensitive to amikacin, ceftazidime, colistin, gentamicin, tobramycin and tetracycline and resistant to ciprofloxacin, cefepime, imipenem, levofloxacin, meropenem, trimethoprim/sulfamethoxazole, and ampicillin/sulbactam with intermediate resistance to ceftriaxone. Strain MRSN 6541 is reported to have two aminoglycoside transferase genes [aadA2 and ant(2”)-Ia; conferring resistance to various aminoglycosides], four beta-lactamase genes (blaADC-25, blacarb-2, blaOAX-25 and blaOXA-69; conferring resistance to beta-lactams), a chloramphenicol acetyltransferase gene (catB3; conferring resistance to chloramphenicol), a chloramphenicol exporter gene (cmlA1; conferring resistance to chloramphenicol), a dihydrofolate reductase (dfrA19; conferring resistance to trimethoprim), a macrolide phosphotransferase [mph(E), conferring resistance to macrolides], a ABC-F type ribosomal protection protein /ABC-F subfamily protein gene [msr(E); conferring resistance to erythromycin and streptogramin B] and a sulfonamide resistance gene (sul2; conferring resistance to sulfonamides) The complete genome of A. baumannii, strain MRSN 6541 is available (GenBank: VHEK00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
肺杆菌（A.Baumannii）（A.Baumannii），菌株MRSN 6541于2012年从美国的人类伤口中分离，作为全球监测计划的一部分.
a. Baumannii ，菌株MRSN 6541作为MRSN 鲍曼杆菌的一部分沉积，Baumannii 从BEI资源获得的多样性面板作为NR-52248. NR-52168被沉积为多基因座序列类型（MLST）ST1，对Amikacin，Ceftazidime，Colistin，庆大霉素，染发蛋白和四环素和抗氰基葡聚糖，头孢哌酮，ImipeNem，左氧氟沙星，梅洛涅伦姆，三甲双胍/磺胺甲恶唑和氨苄青霉素/氨苄青霉素/脉冲患有中间抗性的头孢曲松.据报道菌株MRSN 6541具有两个氨基糖苷类转移酶基因[ AAD A2和蚂蚁（2“） - IA;赋予各种氨基糖苷的耐药性，四种β-内酰胺酶基因（ BLA ADC-25 ， BLA Carb-2 ， bla oax-25 和 bla oxa-69 ;赋予β-内酰胺酸酯，氯霉素乙酰转移酶基因（ Cat B3;赋予氯霉素抗性），一种氯霉素出口基因（ CML A1;赋予氯霉素抗性），二氢脱液还原酶（ DFR A19;赋予Trimethokim的耐药性，Macrolide Phosphotersfare [ MPH （e），赋予大溴体蛋白保护蛋白/ ABC-F亚家族蛋白基因[ MSR （e）;赋予红霉素和链图B的耐药性B]和磺酰胺含量抗性基因（Sul 2;赋予磺酰胺的抗性） a的完整基因组. Baumannii ，RUSTRION MRSN 6541可用（Genbank： vhek00000000 ）.
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养，补充有10％甘油.
patric （Pathosystems资源集成中心）提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2022-04-01
2021-12-21
2024-09-22
2022-04-01
2024-10-20
2021-12-21
2022-03-31
2024-05-19
2022-04-01
2021-12-13
2024-06-25
2022-04-01